About Samplify
Samplify is a company based in Delhi (India) founded in 2021 by Nitin Reja, Michael Reitermann, and Amit Kumar Sinha. Samplify has raised $8.17 million across 6 funding rounds from investors including Loop Capital, Roland Manger and Dan Lupu. The company has 442 employees as of January 31, 2025. Samplify operates in a competitive market with competitors including Titian Software, RxS, STACS DNA, Jeevay Soft and Scaled Solutions Technologies, among others.
- Headquarter Delhi, India
- Employees 442 as on 31 Jan, 2025
- Founders Nitin Reja, Michael Reitermann, Amit Kumar Sinha
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$2.21 M (USD)168as on Mar 31, 2024
-
Net Profit
-$1.14 M (USD)-30as on Mar 31, 2024
-
EBITDA
-$1.13 M (USD)-31as on Mar 31, 2024
-
Total Equity Funding
$8.17 M (USD)
in 6 rounds
-
Latest Funding Round
$2.27 M (USD), Angel Round
Sep 19, 2025
-
Investors
Loop Capital
& 24 more
-
Employee Count
442
as on Jan 31, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Samplify
Unlock access to complete
Unlock access to complete
Funding Insights of Samplify
Samplify has successfully raised a total of $8.17M across 6 strategic funding rounds. The most recent funding activity was a Angel Round of $2.27 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Samplify
Samplify has secured backing from 25 investors, including angel and institutional investors. Prominent investors backing the company include Loop Capital, Roland Manger and Dan Lupu.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Diversified asset management services are provided to institutional clients.
|
Locked | Locked | Locked | |
|
RM
Roland Manger |
Co-founder of Tracxn, active angel investor in Indian startups
|
Locked | Locked | Locked |
Investor details for Samplify
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Samplify
Investment portfolio details for Samplify
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Samplify
Detailed financials for Samplify
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Samplify Comparisons
Peer comparison for Samplify
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Samplify
Samplify operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Titian Software, RxS, STACS DNA, Jeevay Soft and Scaled Solutions Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sample management platforms are developed for researchers.
|
|
| Locked | Locked | Locked |
Sample management solutions for pharmaceutical workflows are provided.
|
|
| Locked | Locked | Locked |
Digital supply chains and sample tracking tool for hospitals
|
|
| Locked | Locked | Locked |
Offers custom software development, IT services, and healthcare solutions globally.
|
|
| Locked | Locked | Locked |
Offers a digital tool for laboratory inventory management in clinical settings.
|
Detailed competitors of Samplify
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Samplify
Complete news archive for Samplify
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samplify
Samplify was founded in 2021.
Samplify is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Amit Kumar Sinha is the current CEO of Samplify. They have also founded this company.
Samplify is a funded company, having raised a total of $8.17M across 6 funding rounds to date.
As of Jan 31, 2025, the latest employee count at Samplify is 442.
Annual revenue of Samplify is $2.21M as on Mar 31, 2024.
Samplify was established in 2021 in Delhi, India, within the healthcare sector. Services focused on sample collection, handling, and transportation are extended to hospitals and diagnostic centers. The platform supports timely specimen management to streamline laboratory operations and patient interactions. Geographic operations are centered in India, addressing needs in diagnostics and medical logistics.
Samplify's top competitors include Titian Software, RxS and STACS DNA.
Samplify has 25 investors. Key investors include Loop Capital, Roland Manger, Dan Lupu, Cem Sertoglu, and Michael Reitermann.
The valuation of Samplify is $12.36M as of Jul 2023.